Alexandra Antunes participated in a Working Group at the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) in Lyon, France, from November 5 to 12, 2024, to finalize the evaluation of the carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus.
The outcome of the assessment has been published in The Lancet Oncology and will be described in detail in Volume 137 of the IARC Monographs, to be published in 2025.
